I. A. Langmoen

543 total citations
10 papers, 437 citations indexed

About

I. A. Langmoen is a scholar working on Cellular and Molecular Neuroscience, Anesthesiology and Pain Medicine and Developmental Neuroscience. According to data from OpenAlex, I. A. Langmoen has authored 10 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cellular and Molecular Neuroscience, 3 papers in Anesthesiology and Pain Medicine and 3 papers in Developmental Neuroscience. Recurrent topics in I. A. Langmoen's work include Neuroscience and Neuropharmacology Research (9 papers), Anesthesia and Sedative Agents (3 papers) and Anesthesia and Neurotoxicity Research (3 papers). I. A. Langmoen is often cited by papers focused on Neuroscience and Neuropharmacology Research (9 papers), Anesthesia and Sedative Agents (3 papers) and Anesthesia and Neurotoxicity Research (3 papers). I. A. Langmoen collaborates with scholars based in Norway, United States and India. I. A. Langmoen's co-authors include John J. Hablitz, Jon Berg–Johnsen, Frode Fonnum, Ragnhild E. Paulsen, P. Andersen, Baruch I. Kanner, Reidun Torp, Fritz Rothe, Niels C. Danbolt and Ole Petter Ottersen and has published in prestigious journals such as Journal of Neuroscience, The Journal of Physiology and Experimental Brain Research.

In The Last Decade

I. A. Langmoen

10 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. A. Langmoen Norway 9 380 224 100 66 45 10 437
Laura C. Daniell United States 16 526 1.4× 353 1.6× 89 0.9× 64 1.0× 31 0.7× 21 630
Jo Ellen Dildy‐Mayfield United States 8 472 1.2× 360 1.6× 92 0.9× 67 1.0× 15 0.3× 8 591
E. MOHACSI Hungary 6 363 1.0× 234 1.0× 103 1.0× 51 0.8× 19 0.4× 12 456
Norman Hershkowitz United States 12 367 1.0× 205 0.9× 89 0.9× 22 0.3× 75 1.7× 28 514
Lisa Samson United States 5 426 1.1× 297 1.3× 29 0.3× 50 0.8× 39 0.9× 5 531
M. Heitz Switzerland 3 396 1.0× 250 1.1× 109 1.1× 51 0.8× 22 0.5× 5 466
Sophie Zeman United Kingdom 11 280 0.7× 183 0.8× 18 0.2× 80 1.2× 50 1.1× 16 454
Kouichi Kawabe Japan 12 300 0.8× 138 0.6× 128 1.3× 36 0.5× 37 0.8× 17 411
Charles F. Zorumski United States 9 450 1.2× 379 1.7× 48 0.5× 26 0.4× 31 0.7× 10 553
Daniel S. Duch United States 12 406 1.1× 424 1.9× 41 0.4× 80 1.2× 33 0.7× 17 611

Countries citing papers authored by I. A. Langmoen

Since Specialization
Citations

This map shows the geographic impact of I. A. Langmoen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. A. Langmoen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. A. Langmoen more than expected).

Fields of papers citing papers by I. A. Langmoen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. A. Langmoen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. A. Langmoen. The network helps show where I. A. Langmoen may publish in the future.

Co-authorship network of co-authors of I. A. Langmoen

This figure shows the co-authorship network connecting the top 25 collaborators of I. A. Langmoen. A scholar is included among the top collaborators of I. A. Langmoen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. A. Langmoen. I. A. Langmoen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Berg–Johnsen, Jon, et al.. (1998). Isoflurane reduces synaptic glutamate release without changing cytosolic free calcium in isolated nerve terminals. European Journal of Anaesthesiology. 15(2). 224–229. 18 indexed citations
2.
Berg–Johnsen, Jon, Ragnhild E. Paulsen, Frode Fonnum, & I. A. Langmoen. (1993). Changes in evoked potentials and amino acid content during fluorocitrate action studied in rat hippocampal cortex. Experimental Brain Research. 96(2). 241–6. 40 indexed citations
3.
Storm‐Mathisen, Jon, Niels C. Danbolt, Fritz Rothe, et al.. (1992). Chapter 19: Ultrastructural immunocytochemical observations on the localization, metabolism and transport of glutamate in normal and ischemic brain tissue. Progress in brain research. 94. 225–241. 73 indexed citations
4.
Berg–Johnsen, Jon, et al.. (1991). Failure of allopurinol to protect against cerebral injury when given after the start of hypoxia. Acta Neurologica Scandinavica. 83(5). 286–288. 3 indexed citations
5.
Berg–Johnsen, Jon & I. A. Langmoen. (1987). Isoflurane hyperpolarizes neurones in rat and human cerebral cortex. Acta Physiologica Scandinavica. 130(4). 679–685. 61 indexed citations
6.
Berg–Johnsen, Jon & I. A. Langmoen. (1986). Isoflurane effects in rat hippocampal cortex: a quantitative evaluation of different cellular sites of action. Acta Physiologica Scandinavica. 128(4). 613–618. 23 indexed citations
7.
Langmoen, I. A., et al.. (1986). N-methyl-D-aspartate receptor antagonists reduce synaptic excitation in the hippocampus. Journal of Neuroscience. 6(1). 102–106. 83 indexed citations
8.
Hablitz, John J. & I. A. Langmoen. (1982). Excitation of hippocampal pyramidal cells by glutamate in the guinea‐pig and rat.. The Journal of Physiology. 325(1). 317–331. 105 indexed citations
9.
Langmoen, I. A. & John J. Hablitz. (1981). Reversal potential for glutamate responses in hippocampal pyramidal cells. Neuroscience Letters. 23(1). 61–65. 14 indexed citations
10.
Andersen, P. & I. A. Langmoen. (1980). Intracellular studies on transmitter effects on neurones in isolated brain slices. Quarterly Reviews of Biophysics. 13(1). 1–18. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026